Skip to content

March 24-26, 2020
San Diego, CA

Improving Patient Care by Advancing Innate Understanding & Enhancing Innate Cell Therapies

What’s On › Speakers

Speakers

Sonny Hsiao

CEO

Acepodia

Stewart Abbot

CSO

Adicet Bio

Joachim Koch

Head Translational Reseach & Innovaiton

Affimed GmbH

Peter Flynn

CTO

Artiva Biotherapeutics Inc.

Robin Parihar

Assistant Proffesor

Baylor College of Medicine

Noah Merin

Professor

Cedars-Sinai Medical Centre

Nassir Habboubi

CMO

Celularity

Emily Mace

Assistant Proffesor

Columbia University in the City of New York

Michael Koslowski

CMO

GammaDelta Therapeutics

Bob Valamehr

CDO

Fate Therapeutics

Amy Sharma

Scientist & Toxicologist, Safety Assessment, Early Development

Genentech

Martha Elia Luevano Salinas

Global Product Manager Innate Lymphocytes

Miltenyi Biotec

Yu-Kyeong Hwang

SVP & Head of Research & Development

Green Cross LabCell

Amir Horowitz

Professor

Icahn School of Medicine at Mount Sinai

Larry Lamb

CSO

Incysus

Evren Alici

CEO

Vycellix

Jeffrey Miller

Professor

University of Minnesota

Elie Haddad

Professor of Paediatrics

University of Montreal

Dean Lee

Director, Cellular Therapy and Cancer Immunotherapy

Nationwide Children's Hospital

Michael O’Dwyer

Professor

NUI Galway

Nick Huntington

CSO

oNKo-Innate Pty Ltd

Karl-Johan Malmberg

Professor

Oslo University

Silke Paust

Associate Professor

Scripps Institute

Carsten Watzl

Professor

Technical University Dortmund

Donna Rill

CTO

Triumvira Immunologics Inc

Anahid Jewett

Professor

University of California Los Angeles

Dan Kaufman

Professor

University of California

Alicja Copik

Research Assistant Professor

University of Central Florida

Alan Epstein

Professor

University of Southern California Keck School of Medicine

Todd Fehniger

Associate Professor

Washington University School of Medicine in St Louis

James Trager

CSO

Nkarta Therapeutics

Cristina Argaiz Equizabal

Chief of Research Unit

Basque Center for Transfusion and Human Tissue

Robert Igarashi

VP, Discovery & Pre-Clinical Development

Kiadis Pharma